191 related articles for article (PubMed ID: 34758848)
21. Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway.
Zhang SJ; Li YF; Wang GE; Tan RR; Tsoi B; Mao GW; Zhai YJ; Cao LF; Chen M; Kurihara H; Wang Q; He RR
Food Funct; 2015 Aug; 6(8):2578-87. PubMed ID: 26114447
[TBL] [Abstract][Full Text] [Related]
22. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
23. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
24. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
Cells; 2019 May; 8(5):. PubMed ID: 31083505
[TBL] [Abstract][Full Text] [Related]
25. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
26. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
27.
Ding M; Zhou F; Li Y; Liu C; Gu Y; Wu J; Fan G; Li Y; Li X
Chin Herb Med; 2023 Jul; 15(3):421-429. PubMed ID: 37538867
[TBL] [Abstract][Full Text] [Related]
28. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
29. Zinc reduces hepatic lipid deposition and activates lipophagy via Zn
Wei CC; Luo Z; Hogstrand C; Xu YH; Wu LX; Chen GH; Pan YX; Song YF
FASEB J; 2018 Jun; ():fj201800463. PubMed ID: 29912588
[TBL] [Abstract][Full Text] [Related]
30. Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-κB Inhibition.
Mao Y; Cheng J; Yu F; Li H; Guo C; Fan X
Cell Physiol Biochem; 2015; 37(2):563-76. PubMed ID: 26329041
[TBL] [Abstract][Full Text] [Related]
31. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
32. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
[TBL] [Abstract][Full Text] [Related]
33. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
[TBL] [Abstract][Full Text] [Related]
34. Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK.
Yang Y; Wu Y; Zou J; Wang YH; Xu MX; Huang W; Yu DJ; Zhang L; Zhang YY; Sun XD
Front Pharmacol; 2021; 12():687095. PubMed ID: 34163366
[No Abstract] [Full Text] [Related]
35. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
36. Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.
Zhou F; Ding M; Gu Y; Fan G; Liu C; Li Y; Sun R; Wu J; Li J; Xue X; Li H; Li X
Front Pharmacol; 2021; 12():826628. PubMed ID: 35087411
[TBL] [Abstract][Full Text] [Related]
37. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy.
Li R; Xin T; Li D; Wang C; Zhu H; Zhou H
Redox Biol; 2018 Sep; 18():229-243. PubMed ID: 30056271
[TBL] [Abstract][Full Text] [Related]
39. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
[TBL] [Abstract][Full Text] [Related]
40. Sulfated glucuronomannan hexasaccharide G6S1 enhanced lipolysis and lipophagy via PPARα pathway.
Cai M; Chen Y; Wang Y; Fang Q; He X; Wu W; Bao Y; Mao G; Jin W; Zhong W
Int J Biochem Cell Biol; 2021 Oct; 139():106067. PubMed ID: 34425199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
